NCT03324555View on ClinicalTrials.gov

Study of ORIC-101 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 19, 2017

Primary Completion Date

December 18, 2017

Study Completion Date

December 18, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

ORIC-101

Oral suspension

Trial Locations (1)

33126

Research Center, Miami

Sponsors
All Listed Sponsors
lead

ORIC Pharmaceuticals

INDUSTRY